BIOA - BioAge Labs, Inc.
4.06
0.110 2.709%
Share volume: 170,259
Last Updated: 05-07-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.13%
PREVIOUS CLOSE
CHG
CHG%
$3.95
0.11
0.03%
View ratios
| Fiscal Date | 09-30-2023 | 09-30-2024 | 12-31-2024 | |
|---|---|---|---|---|
| Fiscal Quarter | Q3 2023 | Q3 2024 | Q4 2024 | |
| Report Date | 11-07-2024 | 11-07-2024 | 03-20-2025 | |
| Total revenue | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | |||
| Operating expenses | 9.887 M | 24.750 M | 0.000 | |
| Selling general and admin | 3.355 M | 4.731 M | 0.000 | |
| Research and development | 6.532 M | 20.019 M | 0.000 | |
| Total expenses | 9.887 M | 24.750 M | 0.000 | |
| 150.33% | -100.00% | |||
| Operating income | -9.887 M | -24.750 M | 0.000 | |
| Ebit | -12.721 M | -25.056 M | 0.000 | |
| Pretax income | -14.625 M | -23.407 M | 0.000 | |
| 60.05% | -100.00% | |||
| Income tax | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | |
| Net income | -14.625 M | -23.407 M | 0.000 | |
| -60.05% | 100.00% |
